Sunitinib (SU11248) in patients with chemo naive extensive small cell lung cancer or who have a ‘chemosensitive’ relapse: A single-arm phase II study (EORTC-08061)
Author:
Publisher
Elsevier BV
Subject
Cancer Research,Oncology
Reference6 articles.
1. Safety and efficacy of sunitinib in patients with unresectable pancreatic neuroendocrine tumors;Wiedmann;Clin Med Insights Oncol,2012
2. Phase II trial of sunitinib maintenance therapy after platinum-based chemotherapy in patients with extensive-stage small cell lung cancer;Schneider;J Thorac Oncol,2011
3. Phase II study of maintenance sunitinib following irinotecan and carboplatin as first-line treatment for patients with extensive-stage small-cell lung cancer;Spigel;Lung Cancer,2012
4. Chemotherapy with or without maintenance sunitinib for untreated extensive-stage small-cell lung cancer: a randomized, double-blind, placebo-controlled phase II study-CALGB 30504 (Alliance);Ready;J Clin Oncol,2015
5. A phase II study of sunitinib in patients with relapsed or refractory small cell lung cancer;Han;Lung Cancer,2013
Cited by 18 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Achieving long-term survival in extensive-stage SCLC: a case report and mini literature review;Lung Cancer Management;2024-01-11
2. Research Progress of Anti-Angiogenic Drugs in First-Line Treatment of Small Cell Lung Cancer;Journal of Biosciences and Medicines;2023
3. Signal pathways and precision therapy of small-cell lung cancer;Signal Transduction and Targeted Therapy;2022-06-15
4. Real-world efficacy and safety of anlotinib as third- or further-line treatment in refractory small cell lung cancer;Journal of Cancer Research and Clinical Oncology;2021-11-08
5. Angiogenesis Inhibitors in Small Cell Lung Cancer;Frontiers in Oncology;2021-05-28
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3